Becton Dickinson (BDX) EBITDA Margin (2009 - 2026)
Becton Dickinson's (BDX) quarterly EBITDA Margin came in at 13.31% in Q2 2026, down 233.0% year-over-year from 10.0% in Q2 2025, and up 574.42% quarter-over-quarter from 1.97% in Q1 2026.
Powered by 
Analysis
Becton Dickinson (BDX) EBITDA Margin (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported EBITDA Margin for 18 consecutive years, with 13.31% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin fell 233.0% year-over-year to 13.31% in Q2 2026; TTM through Jun 2026 was 10.68%, a 41.0% decrease from a year earlier, with the FY2025 full-year figure at 11.81%, down 7.0% from the prior year.
- EBITDA Margin was 13.31% for Q2 2026 at Becton Dickinson, up from 1.97% in the prior quarter.
- Over five years, EBITDA Margin peaked at 15.64% in Q2 2025 and troughed at 1.97% in Q1 2026.
- A 5-year average of 10.99% and a median of 11.51% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin soared 458 bps in 2024 and plunged 658 bps in 2026, its largest moves.
- Over 5 years, EBITDA Margin stood at 12.76% in 2022, then declined by 27 bps to 9.33% in 2023, then decreased by 6 bps to 8.77% in 2024, then climbed by 20 bps to 10.51% in 2025, then climbed by 27 bps to 13.31% in 2026.
- The last three EBITDA Margin figures came in at 13.31% (Q2 2026), 1.97% (Q1 2026), and 10.51% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 13.31% |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 5.14% |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 20.53% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 7.33% |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 12.93% |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 10.89% |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | -5.97% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | -71.46% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.31% |
| Mar 31, 2026 | 1.97% |
| Dec 31, 2025 | 10.51% |
| Sep 30, 2025 | 14.14% |
| Jun 30, 2025 | 15.64% |
| Mar 31, 2025 | 8.55% |
| Dec 31, 2024 | 8.77% |
| Sep 30, 2024 | 11.44% |
| Jun 30, 2024 | 12.06% |
| Mar 31, 2024 | 14.55% |
| Dec 31, 2023 | 9.33% |
| Sep 30, 2023 | 6.86% |
| Jun 30, 2023 | 11.25% |
| Mar 31, 2023 | 13.03% |
| Dec 31, 2022 | 12.76% |
| Sep 30, 2022 | 10.27% |
| Jun 30, 2022 | 11.57% |
| Mar 31, 2022 | 11.87% |
| Dec 31, 2021 | 14.67% |
| Sep 30, 2021 | 7.84% |